• Organizations: Bausch + Lomb
Pivotal study showcases enVista Envy IOL's full range of vision
Research

Pivotal study showcases enVista Envy IOL's full range of vision

Data includes meeting all efficacy and safety outcomes, with the lens demonstrating statistical superiority in visual outcomes and a favorable dysphotopsia profile.
New data reinforces XIIDRA's eye dryness relief among CL wearers
Research

New data reinforces XIIDRA's eye dryness relief among CL wearers

Open-label study evaluated effectiveness of lifitegrast 5%, noting significant improvements in end-of-day dryness and discomfort in just 2 weeks.
Bausch + Lomb launches ASANA gas permeable lenses
Products

Bausch + Lomb launches ASANA gas permeable lenses

Latest addition to the company’s GP lens portfolio is a versatile lens custom designed to provide advanced visual acuity and all-day shape maintenance.
New phase 3 data compares efficacy of Lumify PF to Lumify drops for ocular redness reduction
Research

New phase 3 data compares efficacy of Lumify PF to Lumify drops for ocular redness reduction

Randomized trial reports favorable outcomes in evaluating the safety and efficacy of the preservative-free brimonidine tartrate (0.025%) formulation.
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Business

Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes

Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.
Bausch + Lomb unveils 2025 state of dry eye survey results
Research

Bausch + Lomb unveils 2025 state of dry eye survey results

Building on 2024 findings, latest results indicate a need for more patient education to dispel ongoing misconceptions surrounding dry eye.
Bausch + Lomb launches two new eye drops to Blink portfolio
Products

Bausch + Lomb launches two new eye drops to Blink portfolio

Now available at most U.S. retailers, the latest additions to this specialty product line includes Blink Nourish Lubricating and Blink Boost Lubricating eye drops.
Bausch + Lomb launches PF LUMIFY redness reliever drops
Products

Bausch + Lomb launches PF LUMIFY redness reliever drops

Newest preservative-free, OTC formulation of low-dose brimonidine tartrate is available in single-use vials to relieve eye redness due to minor ocular irritations.
B+L launches Zenlens CHROMA HOA scleral contact lenses
Products

B+L launches Zenlens CHROMA HOA scleral contact lenses

Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.
B+L's enVista IOLs return to market after voluntary recall
Products

B+L's enVista IOLs return to market after voluntary recall

Company announces conclusion of investigation into reported cases of TASS involving the enVista IOL product line. 
B+L issues voluntary recall of certain IOLs in enVista platform
Products

B+L issues voluntary recall of certain IOLs in enVista platform

Recall follows an increase in reports of toxic anterior segment syndrome connected to implants of the enVista Aspire, Envy, and other monofocal IOLs.
Phase 4 data presents early patient-reported outcomes of MIEBO
Pipeline

Phase 4 data presents early patient-reported outcomes of MIEBO

Study finds symptom relief achieved as early as 5 to 60 minutes on day 1 of dosing—with significant reduction in overall severity after 14 days.
Bausch + Lomb launches ortho-k lens fitting system
Products

Bausch + Lomb launches ortho-k lens fitting system

The Arise cloud-based platform syncs directly with diagnostic tools to create a customized lens design for myopia treatment in mere seconds—without the need for a fitting set.
Eyecare companies offering support to LA wildfire victims
Events

Eyecare companies offering support to LA wildfire victims

Industry leaders such as CooperVision, Alcon, Bausch + Lomb, and EssilorLuxottica are providing supplies and services to optometrists and residents in need.
Bausch + Lomb may be acquiring InflammX Therapeutics
Business

Bausch + Lomb may be acquiring InflammX Therapeutics

Option agreement indicates B+L intends to purchase the biotech company and its orally-administered therapeutic under clinical investigation for retinal diseases.
 Bausch + Lomb adds to glaucoma and GA pipeline with two deals
Business

Bausch + Lomb adds to glaucoma and GA pipeline with two deals

Latest developments involve the acquisition of WhiteCap Biosciences and its GA candidate, as well as a partnership with RNAi-focused City Therapeutics.
Bausch + Lomb launches second annual glaucoma awareness campaign
Events

Bausch + Lomb launches second annual glaucoma awareness campaign

As part of a partnership with the Glaucoma Research Foundation, this month-long initiative honors January as Glaucoma Awareness Month.
Bausch + Lomb purchases Elios Vision
Business

Bausch + Lomb purchases Elios Vision

Acquisition includes the ELIOS procedure, an excimer laser-based and implant-free MIGS technology performed during cataract surgery for glaucoma treatment.
Bausch + Lomb demos new Opal online ordering platform
Products

Bausch + Lomb demos new Opal online ordering platform

E-commerce platform lets patients directly order from a customized catalog of products while minimizing and simplifying clinical practices’ administrative workload.
Bausch + Lomb names leading ophthalmologist as strategic medical advisor
Business

Bausch + Lomb names leading ophthalmologist as strategic medical advisor

Industry veteran Cathleen McCabe, MD, will consult on the company’s expanding product portfolio and serve as liaison to the global ECP community.